High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer (vol 12, 931445, 2022)
第一作者机构:[1]Hebei Med Univ, Hosp 4, Dept Gynecol, Shijiazhuang, Peoples R China[2]Tangshan Peoples Hosp, Dept Gynecol, Tangshan, Peoples R China
通讯作者:
通讯机构:[1]Hebei Med Univ, Hosp 4, Dept Gynecol, Shijiazhuang, Peoples R China
推荐引用方式(GB/T 7714):
Zuo Wei-Wei,Zhao Chun-Fang,Li Yan,et al.High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer (vol 12, 931445, 2022)[J].FRONTIERS IN ONCOLOGY.2023,13:doi:10.3389/fonc.2023.1218746.
APA:
Zuo, Wei-Wei,Zhao, Chun-Fang,Li, Yan,Sun, Hai-Yan,Ma, Guo-Ming...&Kang, Shan.(2023).High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer (vol 12, 931445, 2022).FRONTIERS IN ONCOLOGY,13,
MLA:
Zuo, Wei-Wei,et al."High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer (vol 12, 931445, 2022)".FRONTIERS IN ONCOLOGY 13.(2023)